Cargando…
Topiramate and other kainate receptor antagonists for depression: A systematic review of randomized controlled trials
BACKGROUND: Depression is a common disorder that affects patients' quality of life and incurs health system costs. Due to the resistance to treat depression, better understanding of neurophysiology was considered; one of the implications is the glutamatergic system. This study aims to systemati...
Autor principal: | Shamabadi, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773746/ https://www.ncbi.nlm.nih.gov/pubmed/35912516 http://dx.doi.org/10.1002/npr2.12284 |
Ejemplares similares
-
Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials
por: Shamabadi, Ahmad, et al.
Publicado: (2022) -
Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective
por: Chałupnik, Paulina, et al.
Publicado: (2023) -
Trafficking of Kainate Receptors
por: Pahl, Steffen, et al.
Publicado: (2014) -
Therapeutic Potential of Kainate Receptors
por: Matute, Carlos
Publicado: (2010) -
Cortical kainate receptors and behavioral anxiety
por: Zhuo, Min
Publicado: (2017)